Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can hyperprolactinemia cause low testosterone in women?

Elevated prolactin can reduce female testosterone by suppressing gonadotropin signaling and impairing ovarian steroidogenesis.

PlausibleJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Hyperprolactinemia can contribute to low testosterone in women by suppressing gonadotropin signaling and impairing ovarian steroidogenesis.

laying out figure…
0 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes that high prolactin inhibits hypothalamic kisspeptin-GnRH activity, leading to decreased LH/FSH secretion and loss of ovarian theca cell stimulation for androgen production. It also notes direct ovarian effects of prolactin that downregulate steroidogenic enzymes, further reducing ovarian-derived testosterone.

Verified conclusion

The hormonal disruption caused by hyperprolactinemia significantly impacts the female reproductive axis, extending beyond the well-known effects on estrogen to influence total androgen production.

Clinical and effectiveness evidence

Hyperprolactinemia is a primary driver of hypogonadotropic hypogonadism. In this state, elevated prolactin levels create a functional deficiency in the hormones that regulate the ovaries.

  • Gonadotropin suppression: Extensive research confirms that high prolactin levels disrupt the pulsatile release of Gonadotropin-Releasing Hormone (GnRH). This suppression leads to a subsequent decline in the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary.
  • Impact on androgens: In women, approximately 50% of circulating testosterone is derived from the ovaries (either through direct secretion or the peripheral conversion of ovarian androstenedione). Because LH is the primary stimulus for the ovarian theca cells to produce these androgens, the reduction in LH pulses logically results in decreased ovarian testosterone production.
  • Clinical presentation: While clinical studies frequently focus on the resulting estrogen deficiency (leading to amenorrhea or bone density loss), the pathway for testosterone reduction is identical. However, some evidence suggests a complex interaction where prolactin may occasionally increase adrenal androgen precursors like DHEA-S, though this rarely compensates for the loss of ovarian output.

Mechanistic explanations

The suppression occurs through a sophisticated neuroendocrine feedback loop:

  • Kisspeptin inhibition: Prolactin acts directly on the KNDy (Kisspeptin/Neurokinin B/Dynorphin) neurons in the arcuate nucleus of the hypothalamus. It binds to prolactin receptors (Prlrs) on these neurons, directly inhibiting the expression of kisspeptin. Since kisspeptin is the essential "master switch" for GnRH, its absence halts the entire downstream hormonal cascade.
  • Direct ovarian interference: Beyond the brain, prolactin receptors are present on ovarian cells. High levels of prolactin can directly interfere with LH-stimulated androgen synthesis in theca cells and downregulate aromatase (CYP19A1) activity in granulosa cells.
  • Dopaminergic activity: Prolactin increases the activity of tuberoinfundibular dopaminergic (TIDA) neurons. While this is a feedback mechanism to inhibit further prolactin release, the increased dopamine can further suppress GnRH pulsatility via D2 receptors.

Bottom line

Hyperprolactinemia is a recognized cause of low testosterone in women. It works by suppressing the hypothalamic kisspeptin-GnRH axis, which removes the LH stimulation necessary for ovarian theca cells to produce testosterone and its precursors.

References

  1. Acute Suppression of LH Secretion by Prolactin in Female Mice Is Mediated by Kisspeptin Neurons in the Arcuate Nucleus. — academic.oup.com ↗
  2. What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review — pmc.ncbi.nlm.nih.gov ↗
  3. Interactions between prolactin and kisspeptin to control reproduction — pmc.ncbi.nlm.nih.gov ↗
  4. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India — semanticscholar.org ↗
  5. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. — pmc.ncbi.nlm.nih.gov ↗
  6. Effects of prolactin on the proliferation and hormone secretion of ovine granulosa cells in vitro — pmc.ncbi.nlm.nih.gov ↗
  7. Prolactin inhibition of luteinizing hormone-stimulated androgen synthesis in ovarian interstitial cells cultured in defined medium: mechanism of action. — academic.oup.com ↗
  8. Inhibition of MAPK by Prolactin Signaling through the Short Form of Its Receptor in the Ovary and Decidua — pmc.ncbi.nlm.nih.gov ↗
  9. Hyperprolactinaemia – a problem in patients from the reproductive period to the menopause — pmc.ncbi.nlm.nih.gov ↗
  10. Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM) — aem-sbem.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→